Search
Displaying 531–540 of 756 for “retinitis clinical trial”
-
Beacon Stories
Danielle has been navigating her retinitis pigmentosa for half of her life, but she’s never let it hold her back. Her journey with RP underscores the importance of perspective, community of her friends and family’s support, and the relentless pursuit of treatments and cures.
-
Eva Lou Schroeder Watson's Enduring Legacy
Beacon StoriesEva Watson’s life was marked by her dedication to advancing medical research for blinding diseases, and her generous bequest to the Foundation Fighting Blindness ensures her advocacy will endure. Her story highlights the profound impact of her contributions to driving treatments and cures for blinding diseases.
-
Eye on the Cure Podcast | Episode 76: The Lemay-Pelletier Family
Eye on the CureWhen the Lemay-Pelletier family from Montreal learned that three of their four children were losing vision from retinitis pigmentosa, they made the bold decision to spend 15 months traveling the world to give their kids as many visual memories as possible.
-
There are many ways you can support the mission of the Foundation Fighting Blindness in finding treatments and cures for blinding diseases.
-
Eye on the Cure Podcast | Episode 73: Dr. Zuhal Butuner
Eye on the CureDr. Zuhal Butuner talks about her company’s two emerging RNA therapies for LCA10 and USH2A.
-
Foundation News
Innovative Ways to Support Research for Treatments and Cures for Blinding Diseases
-
Eye on the Cure Podcast | Episode 71: Dr. Leonide Saad
Eye on the CureDr. Saad discusses an emerging therapy for Stargardt disease that has performed well in clinical trials.
-
Eye on the Cure Podcast | Episode 69: Dr. Francois Paquet-Durand
Eye on the CureFrancois Paquet-Durand, PhD, a professor from the University of Tübingen and co-founder of the company Mireca, talks to host Ben Shaberman about the long journey of an emerging, Foundation-funded drug for the treatment of certain forms of retinitis pigmentosa. The episode highlights the challenges that scientists often encounter when developing a drug for a retinal disease, and the persistence and tenacity that are required to keep it moving forward.
-
Karen Petrou Appointed as Board Chair of the Foundation Fighting Blindness
Foundation NewsDavid Brint retires after eight years of distinguished service; Petrou to lead effective July 1, 2024.
-
Foundation News
Advancing Research Solutions for PRPH2-Associated Retinal Diseases.
.png)
.png)
